Wockhardt Ltd to Hold 27th Annual General Meeting on August 10, 2026; Seeks Shareholder Approval for ₹3,000 Crore Capital Raise and Key Resolutions
Published on: July 17, 2026, 9:35 p.m. | Source: scanx.trade
Wockhardt Limited has scheduled its 27th AGM for August 10, 2026 via VC/OAVM, with agenda items including adoption of FY 2025-26 financial statements, revision of Executive Chairman Dr. Habil Khorakiwala's remuneration up to ₹10 Crore per annum with a ceiling of ₹15 Crore per annum, and approval for raising capital not exceeding ₹3,000 Crore. Shareholders will also vote on material related party transactions with Wockhardt Bio AG (up to ₹1,000 Crore), CP Pharmaceuticals Limited (up to ₹550 Crore), and Wockhardt UK Limited (up to ₹550 Crore), as well as the redeployment of approximately ₹162.33 Crore of unutilised QIP proceeds from the November 11, 2024 placement. The appointment of Ms. Zahabiya Khorakiwala as Executive Co-chairperson of Wockhardt Bio AG at USD 250,000 per annum is also on the agenda.
